JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.56B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.56B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.17B |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$777M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.82B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.38B |
| 3 |
Apple
AAPL
|
+$977M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$915M |
| 5 |
Walt Disney
DIS
|
+$778M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.46% |
| 2 | Technology | 11.62% |
| 3 | Healthcare | 10.99% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Marcus Corp
MCS
$897M
| $1.81M | ﹤0.01% |
45,781
+40,265
| +730% | +$1.66M |
|
3202
CALL
Nektar Therapeutics
NKTR
$2.39B
| $1.81M | ﹤0.01% |
3,667
+2,667
| +267% | +$1.61M |
|
|
CPRX
3203
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.8M | ﹤0.01% |
939,138
-49,942
| -5% | -$143K |
|
|
PMT
3204
PennyMac Mortgage Investment
PMT
$822M
| $1.8M | ﹤0.01% |
96,868
+7,806
| +9% | +$156K |
|
3205
Seres Therapeutics
MCRB
$46.8M
| $1.8M | ﹤0.01% |
19,940
-1,135
| -5% | -$159K |
|
|
NVEE
3206
DELISTED
NV5 Global
NVEE
| $1.8M | ﹤0.01% |
119,012
+110,324
| +1,270% | +$2.05M |
|
3207
Aramark
ARMK
$15B
| $1.8M | ﹤0.01% |
86,033
-547,821
| -86% | -$14.2M |
|
|
HOLI
3208
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $1.79M | ﹤0.01% |
102,439
+3,143
| +3% | +$59.9K |
|
3209
CALL
PNC Financial Services
PNC
$99.7B
| $1.79M | ﹤0.01% |
+15,300
| New | +$1.95M |
|
3210
United Natural Foods
UNFI
$3.08B
| $1.79M | ﹤0.01% |
168,729
-146,345
| -46% | -$3.08M |
|
3211
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
| $1.79M | ﹤0.01% |
14,378
+2,737
| +24% | +$374K |
|
3212
CALL
Pacific Biosciences
PACB
$435M
| $1.78M | ﹤0.01% |
+241,200
| New | +$1.53M |
|
3213
Fidelity MSCI Health Care Index ETF
FHLC
$3.28B
| $1.78M | ﹤0.01% |
43,150
+38,402
| +809% | +$1.69M |
|
|
SYBX
3214
DELISTED
Synlogic
SYBX
| $1.78M | ﹤0.01% |
16,956
+519
| +3% | +$68.3K |
|
|
USCR
3215
DELISTED
U S Concrete, Inc.
USCR
| $1.78M | ﹤0.01% |
50,545
-4,956
| -9% | -$179K |
|
3216
US Physical Therapy
USPH
$1.2B
| $1.78M | ﹤0.01% |
17,353
+14,045
| +425% | +$1.56M |
|
|
VSI
3217
DELISTED
Vitamin Shoppe Inc.
VSI
| $1.77M | ﹤0.01% |
374,560
+167,690
| +81% | +$1.26M |
|
|
TVRD
3218
Tvardi Therapeutics
TVRD
$19.7M
| $1.77M | ﹤0.01% |
3,778
+74
| +2% | +$47.7K |
|
|
STL
3219
DELISTED
Sterling Bancorp
STL
| $1.77M | ﹤0.01% |
106,971
+9,223
| +9% | +$172K |
|
3220
VanEck Merk Gold Trust
OUNZ
$2.51B
| $1.76M | ﹤0.01% |
140,001
+140,000
| +14,000,000% | +$1.69M |
|
|
UHT
3221
Universal Health Realty Income Trust
UHT
$603M
| $1.76M | ﹤0.01% |
28,719
+11,421
| +66% | +$774K |
|
|
CTXS
3222
PUT
DELISTED
Citrix Systems Inc
CTXS
| $1.76M | ﹤0.01% |
17,200
-10,000
| -37% | -$1.06M |
|
3223
CALL
Kinder Morgan
KMI
$71.7B
| $1.76M | ﹤0.01% |
114,500
+14,500
| +15% | +$245K |
|
3224
Guardant Health
GH
$21.7B
| $1.75M | ﹤0.01% |
+46,682
| New | +$1.72M |
|
3225
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
| $1.75M | ﹤0.01% |
19,164
+14,392
| +302% | +$1.32M |
|
Similar funds
JP Morgan Chase's Q4 2018 Portfolio in Review
As of Q4 2018, JP Morgan Chase held 6,191 positions worth $432B, down 17% from $522B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase withdrew a net $17.1B in Q4 2018, closing 424 positions and reducing 2,219 holdings. Its most notable exit was Energen, an estimated $648M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Linde worth $751M.
- JP Morgan Chase's largest Q4 2018 buy was Linde: 4,813,392 shares worth $751M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2018, an estimated $1.56B increase.
- JP Morgan Chase's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.82B.
- JP Morgan Chase fully exited Energen in Q4 2018, selling an estimated $648M.
- JP Morgan Chase's ten largest holdings make up 16% of its $432B portfolio in Q4 2018.
- JP Morgan Chase opened 487 new positions and closed 424 in Q4 2018.
- JP Morgan Chase's portfolio value fell 17% quarter-over-quarter to $432B.
Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.